Dutasteride

Dutasteride · DUTASTERIDE .5 mg/1 · Capsule · Oral · Amneal Pharmaceuticals LLC

NDC 65162-0750-03 · 30 CAPSULE in 1 BOTTLE · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.1958 per unit over the past year.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built

Data sources

CMS NADAC (pharmacy acquisition, weekly)
CMS Part B ASP quarterly payment limits
CMS Maximum Fair Prices (IRA negotiated, NDC-level)
Medicare Part D Spending by Drug (data.cms.gov, name-matched)
VA FSS / Big4 federal contract prices (va.gov, twice monthly)
ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
California SB-17 WAC filings (list price, per package)

Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Part D plans paid (avg)$0.4639per dosage unitgross, before rebates — matched by drug name · 2024
Medicaid generic ceiling (FUL)$0.3512per CAPweighted avg manufacturer price $0.2007 · Nov 1, 2023

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

99 price points · per · last surveyed Invalid Date · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

WAC per package, as filed

$15.00

Reported to Texas DSHS · 2023 annual filing · Amneal Pharmaceuticals LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2023)

$661

34 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for dutasteride (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Amneal Pharmaceuticals of New York, LLCUnited States
analysis · label · manufacture

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application: ANDA203118
TE code: AB
Approval date: Nov 20, 2015
Patents / exclusivity: None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dutasteride (Capsule)

Labeler	Strength	First seen	Last seen
Catalent Pharma Solutions, LLC	DUTASTERIDE .5 mg/1	Jul 15, 2026	Sep 3, 2026
Amneal Pharmaceuticals LLC	DUTASTERIDE .5 mg/1	Jul 15, 2026	Sep 2, 2026
Banyan Pharma LLC	DUTASTERIDE .5 mg/1	Jul 15, 2026	Sep 2, 2026
Proficient Rx LP	DUTASTERIDE .5 mg/1	Jul 15, 2026	Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dutasteride — NDC 65162-0750-03," retrieved September 3, 2026, https://drugdashboards.com/drug/65162075003.

Free to cite with attribution — see how the data is put together.